-
Sector Analysis
Aspergillosis: Market View, Current and Future Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Aspergillosis Therapeutics. • In 2024 and 2029, India is anticipated to have the highest number of diagnosed incident cases of aspergillosis, representing a large portion of global cases. • Currently, the aspergillosis market is saturated with generic drugs. Triazoles, polyenes, and echinocandins are primarily used to manage aspergillosis. • The aspergillosis pipeline holds 37 molecules, with no assets in the pre-registration stage, four assets in Phase...
-
Thematic Analysis
Pharma M&A Deals 2025 - Top Themes: Strategic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2025 in the pharma Sector.
-
Sector Analysis
Myopia and Pediatric Myopia Progression: Market View, Current and Future Competitive Landscape
Understand the Future of the Myopia Therapeutics Market Myopia and pediatric myopia progression are becoming increasingly important areas within ophthalmology. This report helps you understand how the competitive landscape is evolving across treatments, pipeline assets and clinical activity. You will gain insight into disease prevalence, treatment approaches and pipeline development. Moreover, the report highlights how innovation is shaping the future of therapeutics in this space. As a result, you can better assess where opportunities may emerge across the market. Report...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, January 2026
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Product Insights
Hypertrophic Cardiomyopathy - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Hypertrophic Cardiomyopathy - Global Clinical Trials Review, 2026" provides an overview of Hypertrophic Cardiomyopathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertrophic Cardiomyopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Huntington Disease - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Huntington Disease - Global Clinical Trials Review, 2026" provides an overview of Huntington Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Huntington Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Malaria - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Malaria - Global Clinical Trials Review, 2026" provides an overview of Malaria Clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2026" provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Post-Traumatic Stress Disorder (PTSD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Rheumatoid Arthritis - Global Clinical Trials Review, 2026
Understand the Global Clinical Trials Landscape for Rheumatoid Arthritis Rheumatoid arthritis remains a key focus area in global clinical research, with ongoing trials shaping the future of treatment and innovation. This report provides a comprehensive snapshot of the global clinical trials landscape, covering trial activity across regions, countries (G7 & E7), phases, statuses, endpoints, and sponsor types. As a result, you gain a clear understanding of where research is accelerating and how the competitive landscape is evolving. Report Value Proposition...
-
Product Insights
Hyperuricemia - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Hyperuricemia - Global Clinical Trials Review, 2026" provides an overview of Hyperuricemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.